These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 8017721

  • 21. Race, sex, drug use, and progression of human immunodeficiency virus disease.
    Chaisson RE, Keruly JC, Moore RD.
    N Engl J Med; 1995 Sep 21; 333(12):751-6. PubMed ID: 7643881
    [Abstract] [Full Text] [Related]

  • 22. Acyclovir in combination with zidovudine does not prolong survival in advanced HIV disease.
    Erbelding EJ, Chaisson RE, Gallant JE, Moore RD.
    Antivir Ther; 1997 Apr 21; 2(2):71-7. PubMed ID: 11322278
    [Abstract] [Full Text] [Related]

  • 23. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.
    Wannamethee SG, Sirivichayakul S, Phillips AN, Ubolyam S, Ruxrungtham K, Hanvanich M, Phanuphak P.
    Int J Epidemiol; 1998 Apr 21; 27(2):289-95. PubMed ID: 9602412
    [Abstract] [Full Text] [Related]

  • 24. The effects on survival of early treatment of human immunodeficiency virus infection.
    Graham NM, Zeger SL, Park LP, Vermund SH, Detels R, Rinaldo CR, Phair JP.
    N Engl J Med; 1992 Apr 16; 326(16):1037-42. PubMed ID: 1347907
    [Abstract] [Full Text] [Related]

  • 25. Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study.
    Graham NM, Zeger SL, Park LP, Phair JP, Detels R, Vermund SH, Ho M, Saah AJ.
    Lancet; 1991 Aug 03; 338(8762):265-9. PubMed ID: 1677108
    [Abstract] [Full Text] [Related]

  • 26. CD4 count and the risk for death in patients infected with HIV receiving antiretroviral therapy.
    Yarchoan R, Venzon DJ, Pluda JM, Lietzau J, Wyvill KM, Tsiatis AA, Steinberg SM, Broder S.
    Ann Intern Med; 1991 Aug 01; 115(3):184-9. PubMed ID: 1676252
    [Abstract] [Full Text] [Related]

  • 27. Prognostic factors in human immunodeficiency virus-positive patients with a CD4+ lymphocyte count < 50/microL.
    Apolonio EG, Hoover DR, He Y, Saah AJ, Lyter DW, Detels R, Kaslow RA, Phair JP.
    J Infect Dis; 1995 Apr 01; 171(4):829-36. PubMed ID: 7706809
    [Abstract] [Full Text] [Related]

  • 28. The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: a double-blind randomized trial. European-Australian Collaborative Group.
    Cooper DA, Pehrson PO, Pedersen C, Moroni M, Oksenhendler E, Rozenbaum W, Clumeck N, Faber V, Stille W, Hirschel B.
    AIDS; 1993 Feb 01; 7(2):197-207. PubMed ID: 8096703
    [Abstract] [Full Text] [Related]

  • 29. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
    Volberding PA, Lagakos SW, Koch MA, Pettinelli C, Myers MW, Booth DK, Balfour HH, Reichman RC, Bartlett JA, Hirsch MS.
    N Engl J Med; 1990 Apr 05; 322(14):941-9. PubMed ID: 1969115
    [Abstract] [Full Text] [Related]

  • 30. Duration of the survival benefit of zidovudine therapy in HIV infection.
    Moore RD, Keruly JC, Chaisson RE.
    Arch Intern Med; 1996 May 27; 156(10):1073-7. PubMed ID: 8638994
    [Abstract] [Full Text] [Related]

  • 31. Long-term follow-up of zidovudine therapy in asymptomatic HIV infection: results of a multicenter cohort study. The Italian Zidovudine Evaluation Group.
    Vella S, Giuliano M, Dally LG, Agresti MG, Tomino C, Floridia M, Chiesi A, Fragola V, Moroni M, Piazza M.
    J Acquir Immune Defic Syndr (1988); 1994 Jan 27; 7(1):31-8. PubMed ID: 7903380
    [Abstract] [Full Text] [Related]

  • 32. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
    Chaisson RE, Moore RD, Richman DD, Keruly J, Creagh T.
    Am Rev Respir Dis; 1992 Aug 27; 146(2):285-9. PubMed ID: 1362634
    [Abstract] [Full Text] [Related]

  • 33. Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group.
    Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE.
    Arch Intern Med; 1994 Mar 14; 154(5):566-72. PubMed ID: 8122950
    [Abstract] [Full Text] [Related]

  • 34. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul 14; 8(7):911-21. PubMed ID: 7946100
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of the effectiveness of highly active antiretroviral therapy in persons with human immunodeficiency virus using biomarker-based equivalence of disease progression.
    Jacobson LP, Li R, Phair J, Margolick JB, Rinaldo CR, Detels R, Muñoz A.
    Am J Epidemiol; 2002 Apr 15; 155(8):760-70. PubMed ID: 11943695
    [Abstract] [Full Text] [Related]

  • 36. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
    Fischl MA, Richman DD, Hansen N, Collier AC, Carey JT, Para MF, Hardy WD, Dolin R, Powderly WG, Allan JD.
    Ann Intern Med; 1990 May 15; 112(10):727-37. PubMed ID: 1970466
    [Abstract] [Full Text] [Related]

  • 37. Non-Hodgkin's lymphoma in patients with advanced HIV infection treated with zidovudine.
    Moore RD, Kessler H, Richman DD, Flexner C, Chaisson RE.
    JAMA; 1991 May 01; 265(17):2208-11. PubMed ID: 2013953
    [Abstract] [Full Text] [Related]

  • 38. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.
    Hogg RS, Heath KV, Yip B, Craib KJ, O'Shaughnessy MV, Schechter MT, Montaner JS.
    JAMA; 1998 Feb 11; 279(6):450-4. PubMed ID: 9466638
    [Abstract] [Full Text] [Related]

  • 39. Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group.
    Easterbrook PJ, Keruly JC, Creagh-Kirk T, Richman DD, Chaisson RE, Moore RD.
    JAMA; 1991 Nov 20; 266(19):2713-8. PubMed ID: 1942423
    [Abstract] [Full Text] [Related]

  • 40. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
    Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, Eron JJ, Feinberg JE, Balfour HH, Deyton LR, Chodakewitz JA, Fischl MA.
    N Engl J Med; 1997 Sep 11; 337(11):725-33. PubMed ID: 9287227
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.